SCHEMBL449936

SCHEMBL449936

O=S(=O)(Cc1cccc(Nc2c(Cl)cc(Cl)cc2Cl)c1)NCCOCCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
KCNH3 Q9ULD8 1/20 0.36
ENPP2 Q13822 1/20 0.34
TOP2A P11388 1/20 0.34
TOP2B Q02880 1/20 0.34
ACLY P53396 1/20 0.34
ABL1 P00519 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
NPC1 O15118 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TBXA2R P21731 1/20 0.33
AURKA O14965 2/20 0.33
AURKB Q96GD4 2/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL451746 0.89 LMNA (0.41) ALDH1A1HPGDMEN1KMT2AAURKA
SCHEMBL438018 0.89 TOP2A (0.38) ALDH1A1ENPP2TOP2ATOP2BACLY
SCHEMBL30794731 0.79 CAMK2A (0.41) ALDH1A1KMT2ATBXA2R
SCHEMBL448080 0.79 CAMK2A (0.41) ALDH1A1KMT2ATBXA2R
SCHEMBL448016 0.73 ALDH1A1 (0.41) ALDH1A1ACLYKDM4ETP53MAPT
SCHEMBL450312 0.72 PTGS2 (0.48) KMT2ATBXA2R
SCHEMBL30794451 0.72 PTGS2 (0.48) KMT2ATBXA2R
SCHEMBL439443 0.71 CYP2C19 (0.51) ALDH1A1KDM4EKMT2ATBXA2RAURKA
SCHEMBL1578768 0.70 HPGD (0.46) ALDH1A1HPGDMEN1KMT2A
SCHEMBL448838 0.69 CYP2C9 (0.39) KMT2ATBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231594-B1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF UNIV RAMOT (IL) 2013-03-27 EP claimed
US-20120065270-A1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2012-03-15 US claimed
EP-2231594-A2 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF Ramot at Tel-Aviv University Ltd (IL) 2010-09-29 EP claimed
WO-2009071947-A2 POTASSIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2009-06-11 WO claimed
US-8466201-B2 Potassium ion channel modulators and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2013-06-18 US disclosed
EP-2231594-B1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF UNIV RAMOT (IL) 2013-03-27 EP disclosed
US-20120065270-A1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2012-03-15 US disclosed
EP-2231594-A2 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF Ramot at Tel-Aviv University Ltd (IL) 2010-09-29 EP disclosed
WO-2009071947-A2 POTASSIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065270-A1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF KCNN3, SCN2B, SCN1B ALDH1A1 2956/4885HPGD 4145/4885KCNH3 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.